Back to Trades
BVF PARTNERS L P/IL
10% OwnerCIK 0001055947
Total Volume
$195.2M
10 filings
Purchases
$0
0 buy txns
Sales
$173.7M
7 sell txns
Net Activity
-$173.7M
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 7
- Companies
- 7
- Active
- 2025–2026
Across 10 filings between 2025–2026, BVF PARTNERS L P/IL, 10% Owner, has disclosed $195.2M in transactions — spread across 7 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $173.7M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Jul 16 | XOMA XOMA Royalty Corp | BVF PARTNERS L P/IL | 10% Owner | Other | $0 |
| Jun 26 | KYMR Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Sell | $173.7M |
| Jun 25 | KYMR Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Award | $606.0K |
| Jun 23 | OLMA Olema Pharmaceuticals, Inc. | BVF PARTNERS L P/IL | Director | Award | $280.5K |
| Jun 22 | MLTX MoonLake Immunotherapeutics | BVF PARTNERS L P/IL | Director, 10% Owner | Award | $425.9K |
| May 18 | XOMA XOMA Royalty Corp | BVF PARTNERS L P/IL | 10% Owner | Conversion | $20.2M |
| Feb 27 | IMUX IMMUNIC, INC. | BVF PARTNERS L P/IL | Director | Other | $0 |
| Jan 30 | RPTX Repare Therapeutics Inc. | BVF PARTNERS L P/IL | 10% Owner | Other | $0 |
| Oct 14 | EPIX ESSA Pharma Inc. | BVF PARTNERS L P/IL | 10% Owner | Other | $0 |
| Aug 7 | EPIX ESSA Pharma Inc. | BVF PARTNERS L P/IL | 10% Owner | Sell | $293 |
10 filings